MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Prolium Bioscience, Inc.
Attachments
Prolium Bio
Parents
*Architects: Biotechnology _Monoclonal, Polyclonal, Bispecific Antibodies & Antibody-Drug Conjugates (ADC)s
*Industry: New York City
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Venture Capital: Series A
Children
Finance & Acquisition: Prolium Bioscience
Founded 2025
Key People: Prolium Bioscience
New York City, New York
Organization & Developments: Prolium Bioscience
Jumps
*Licensed a bispecific TCE, now called OM336, from Chinese biotech Keymed Biosciences.
Keymed Biosciences